Published in Stroke on January 19, 2006
Neighborhood socioeconomic disadvantage and mortality after stroke. Neurology (2013) 2.74
Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab (2010) 1.85
Neighborhood income and stroke care and outcomes. Neurology (2012) 1.56
Socioeconomic variation in incidence of primary and secondary major cardiovascular disease events: an Australian population-based prospective cohort study. Int J Equity Health (2016) 1.38
Neighborhood disadvantage and ischemic stroke: the Cardiovascular Health Study (CHS). Stroke (2011) 1.07
Effect of socioeconomic status on functional and motor recovery after stroke: a European multicentre study. J Neurol Neurosurg Psychiatry (2006) 1.05
Declining rates of fatal and nonfatal intracerebral hemorrhage: epidemiological trends in Australia. J Am Heart Assoc (2014) 0.82
Impact of neighborhood socioeconomic conditions on the risk of stroke in Japan. J Epidemiol (2015) 0.79
Outcomes after acute ischemic stroke in the United States: does residential ZIP code matter? J Am Heart Assoc (2015) 0.78
Impact of socio-economic factors on stroke prevalence among urban and rural residents in Mainland China. BMC Public Health (2008) 0.77
Exploring psychosocial pathways between neighbourhood characteristics and stroke in older adults: the cardiovascular health study. Age Ageing (2012) 0.76
Neighborhood Differences in Post-Stroke Mortality. Circ Cardiovasc Qual Outcomes (2017) 0.75
Neighborhood socioeconomic index and stroke incidence in a national cohort of blacks and whites. Neurology (2016) 0.75
A call for transparent reporting to optimize the predictive value of preclinical research. Nature (2012) 14.63
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet (2010) 12.21
Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med (2015) 12.06
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol (2008) 9.02
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med (2003) 7.74
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
1,026 experimental treatments in acute stroke. Ann Neurol (2006) 7.23
Can animal models of disease reliably inform human studies? PLoS Med (2010) 6.27
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol (2010) 5.58
Pooling of animal experimental data reveals influence of study design and publication bias. Stroke (2004) 4.37
Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke (2008) 3.87
Very early mobilization after stroke fast-tracks return to walking: further results from the phase II AVERT randomized controlled trial. Stroke (2010) 3.43
Good laboratory practice: preventing introduction of bias at the bench. Stroke (2008) 3.27
Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J Cereb Blood Flow Metab (2005) 3.20
Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain (2007) 2.94
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77
Improving the translational hit of experimental treatments in multiple sclerosis. Mult Scler (2010) 2.73
Evaluation of excess significance bias in animal studies of neurological diseases. PLoS Biol (2013) 2.70
Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease. Arch Intern Med (2003) 2.68
Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med (2002) 2.54
More doctors, but not enough: Australian medical workforce supply 2001-2012. Med J Aust (2006) 2.51
A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust N Z J Psychiatry (2011) 2.44
The challenges of population ageing: accelerating demand for emergency ambulance services by older patients, 1995-2015. Med J Aust (2011) 2.42
Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. N Engl J Med (2012) 2.39
Randomized trial of constraint-induced movement therapy and bimanual training on activity outcomes for children with congenital hemiplegia. Dev Med Child Neurol (2011) 2.34
Performance of the ABCD2 score for stroke risk post TIA: meta-analysis and probability modeling. Neurology (2012) 2.26
Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke. Ann Neurol (2002) 2.25
Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension (2007) 2.13
The Avoid Stroke as Soon as Possible (ASAP) general practice stroke audit. Med J Aust (2002) 2.13
Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J Stroke Cerebrovasc Dis (2009) 2.12
Who is responsible for the care of patients treated with warfarin therapy? Med J Aust (2009) 2.11
Therapeutic hypothermia and the risk of infection: a systematic review and meta-analysis. Crit Care Med (2014) 2.05
Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke (2011) 2.03
Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin? Stroke (2004) 2.02
Effective prophylaxis for deep venous thrombosis after stroke: both low-dose anticoagulation and stockings for most cases. Stroke (2004) 2.00
Does abnormal circadian blood pressure pattern really matter in patients with transient ischemic attack or minor stroke? Stroke (2014) 1.98
World Stroke Organization global stroke services guidelines and action plan. Int J Stroke (2014) 1.94
Brachial blood pressure but not carotid arterial waveforms predict cardiovascular events in elderly female hypertensives. Hypertension (2006) 1.90
Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis. J Cereb Blood Flow Metab (2010) 1.89
Development of clinical-quality registries in Australia: the way forward. Med J Aust (2011) 1.87
Therapeutic hypothermia for acute ischemic stroke: ready to start large randomized trials? J Cereb Blood Flow Metab (2010) 1.85
Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet (2012) 1.81
Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis (2002) 1.78
Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underused. Med J Aust (2007) 1.71
Pretreatment diffusion- and perfusion-MR lesion volumes have a crucial influence on clinical response to stroke thrombolysis. J Cereb Blood Flow Metab (2010) 1.68
Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol (2006) 1.67
Incidence of stroke subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): differences between men and women. Neuroepidemiology (2008) 1.67
Acute stroke imaging research roadmap. Stroke (2008) 1.66
Determinants of occurrence of aortic sclerosis in an aging population. JACC Cardiovasc Imaging (2009) 1.64
Dopamine agonists in animal models of Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord (2011) 1.64
Evidence-based care and outcomes of acute stroke managed in hospital specialty units. Med J Aust (2003) 1.61
Risk of ischemic stroke among users of the oral contraceptive pill: The Melbourne Risk Factor Study (MERFS) Group. Stroke (2003) 1.59
Quality of life after stroke: the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke (2004) 1.59
Frequent early cardiac complications contribute to worse stroke outcome in atrial fibrillation. Cerebrovasc Dis (2011) 1.53
Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke (2011) 1.52
Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation. Cerebrovasc Dis (2013) 1.52
Predictors of mortality, length of stay and discharge destination in blunt trauma. ANZ J Surg (2005) 1.52
Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls. J Clin Psychiatry (2010) 1.51
Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage study. Cancer (2014) 1.50
Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke (2014) 1.49
Excessive incidence of stroke in Iran: evidence from the Mashhad Stroke Incidence Study (MSIS), a population-based study of stroke in the Middle East. Stroke (2009) 1.49
Ageing and gait variability--a population-based study of older people. Age Ageing (2010) 1.48
Greater daily defined dose of antihypertensive medication increases the risk of falls in older people--a population-based study. J Am Geriatr Soc (2014) 1.48
Riding the wave: current and emerging trends in graduates from Australian university medical schools. Med J Aust (2007) 1.48
Fenitrothion: toxicokinetics and toxicologic evaluation in human volunteers. Environ Health Perspect (2003) 1.48
Source of microembolic signals in patients with high-grade carotid stenosis. Stroke (2002) 1.48
Epidemiological modelling (including economic modelling) and its role in preventive drug therapy. Med J Aust (2002) 1.47
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab (2011) 1.47
Thrombolysis for acute stroke in Australia: outcomes from the Safe Implementation of Thrombolysis in Stroke registry (2002-2008). Med J Aust (2010) 1.47
Reprint: Good laboratory practice: preventing introduction of bias at the bench. J Cereb Blood Flow Metab (2008) 1.47
Demand at the emergency department front door: 10-year trends in presentations. Med J Aust (2012) 1.46
A systematic review and meta-analysis of erythropoietin in experimental stroke. J Cereb Blood Flow Metab (2009) 1.45
Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust (2003) 1.44
Public funding of large-scale clinical trials in Australia. Med J Aust (2003) 1.44
MRI and stroke: why has it taken so long? Lancet (2007) 1.44
Greater effect of stroke thrombolysis in the presence of arterial obstruction. Ann Neurol (2011) 1.44
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011. Med J Aust (2013) 1.43
Pharmacotherapies for obesity: past, current, and future therapies. J Obes (2010) 1.43
Enhancing the development and approval of acute stroke therapies: Stroke Therapy Academic Industry roundtable. Stroke (2005) 1.42